FDA Import Refusal BNI-0103262-0/31/1E — Capital O2 Natural Health Company Ltd
The FDA refused shipment BNI-0103262-0/31/1E from Capital O2 Natural Health Company Ltd (Ghana) on Jan 6, 2022. The refused product falls under Drugs and Biologics — SUPPRESSANT N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 6, 2022
- Country
- Ghana
- Product Category
- Drugs and Biologics
- Product Code
- 66FBL99 SUPPRESSANT N.E.C.
- Charges
- 75